Plant Expression Enhancers for High-Yield Protein Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing recombinant proteins in plants are time-consuming and labor-intensive, and existing plant virus-based expression systems, while offering rapid and high-level transient expression, can be improved for enhanced protein production efficiency.

Innovation Solution

The development of novel expression enhancers such as nbMT78, nbATL75, nbDJ46, nbCHP79, nbEN42, atHSP69, atGRP62, atPK65, nb30S72, nbGT61, nbPV55, nbPPI43, nbPM64, and nbH2A86, which are operatively linked to nucleic acids encoding proteins of interest, significantly increase protein expression levels when compared to traditional CPMV 160 enhancers, facilitating efficient protein production in plants.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Speed

If plant virus-based expression vectors are used for rapid transient expression, then protein production speed is improved, but expression level and efficiency are insufficient

Engineering Contradiction:
Improveprotein production speedVSAvoidprotein expression level
Core Design Contradiction:
SpeedVSQuantity of substance

Solution Approach 1:

The patent combines multiple expression enhancer elements (5'UTR sequences from NbPsaK2, AtPsaK, and other sources) into a single integrated enhancer structure. This merging of complementary functional elements from different origins creates a synergistic effect that simultaneously achieves rapid transient expression and high-level protein production, resolving the contradiction between speed and quantity.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The expression enhancer is constructed as a composite nucleic acid structure incorporating sequences from multiple sources (NbPsaK2 5'UTR, AtPsaK 5'UTR, and additional enhancer elements). This composite design integrates the advantageous properties of each component sequence to achieve both rapid expression kinetics and high protein yield, overcoming the limitations of single-source enhancers.

Inventive Principle:
Principle #40Composite materials

2Device complexity

If traditional CPMV 160 enhancers are used, then system simplicity is maintained, but protein production efficiency is limited

Engineering Contradiction:
Improveenhancer structure simplicityVSAvoidprotein production efficiency
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The patent optimizes specific parameters of the enhancer structure by selecting and combining 5'UTR sequences with proven high-expression characteristics from NbPsaK2 and AtPsaK. By changing the nucleic acid sequence parameters and structural organization, the system achieves dramatically improved protein production efficiency while maintaining the fundamental simplicity of the viral vector platform.

Inventive Principle:
Principle #35Parameter changes

3Duration of action of stationary object

If stable transgenic plant lines are generated, then long-term protein production is achieved, but time consumption and labor intensity increase

Engineering Contradiction:
Improvelong-term protein productionVSAvoidtime consumption for line generation
Core Design Contradiction:
Duration of action of stationary objectVSLoss of time

Solution Approach 1:

The patent incorporates pre-optimized expression enhancer elements into the viral vector system beforehand, allowing for immediate high-level expression upon infection without requiring prior stable transformation of plant lines. This preliminary preparation of enhanced expression machinery in the vector enables rapid transient expression that achieves high productivity without the time-consuming process of generating stable transgenic lines.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS12180491B2Plant expression enhancer
Publication Date: 2024.12.31 ARAMIS BIOTECHNOLOGIES INC
  • US12180491B2 patent drawing
  • US12180491B2 patent drawing
  • US12180491B2 patent drawing

AI summary

An isolated expression enhancer active in a plant, portion of a plant or plant cell, the expression enhancer is provided. The isolated expression enhancer may be selected from the group consisting of nbMT78 (SEQ ID NO:1); nbATL75 (SEQ ID NO:2); nbDJ46 (SEQ ID NO:3); nbCHP79 (SEQ ID NO:4); nbEN42 (SEQ ID NO:5); atHSP69 (SEQ ID NO:6); atGRP62 (SEQ ID NO:7); atPK65 (SEQ ID NO:8); atRP46 (SEQ ID NO:9); nb30S72 (SEQ ID NO:10); nbGT61 (SEQ ID NO:11); nbPV55 (SEQ ID NO:12); nbPPI43 (SEQ ID NO:13); nbPM64 (SEQ ID NO:14); and nbH2A86 (SEQ ID NO:15). Methods for using the isolated expression enhancer are also provided.